Morgan Stanley sees profound shift in diabetes treatment

Morgan Stanley analysts said they are seeing a profound shift in the way diabetes is treated, with doctors focusing more on weight management, accelerating the rollout of GLP-1 drugs. What’s more, analysts predict that within the next 24 months, this weight-focused approach will begin to spread to other health complications—from heart failure to sleep apnea […]